Abstract:Introduction: Allergic contact dermatitis (ACD) is a skin disease characterized by eczema and itching. A considerable proportion of chemicals induce ACD in humans. More than 10,000 substances should be tested for skin sensitization potential under the Registration, Evaluation, Authorization and Restriction of Chemical substances (REACH) regulation. The Local Lymph Node Assay (LLNA) has been designated as the first-choice in vivo assay for sensitization testing by REACH. The LLNA: BrdU-ELISA is a validated non-radioactivemodification to the LLNA. For both the LLNA and the LLNA: BrdU-ELISA, CBA/JNmouse is the preferred mouse strain recommended in the regulatory guidelines. However, the availability of CBA/JN mouse in China is only limited to a few animal suppliers, whichmakes themouse difficult to obtain. BALB/cmouse, which iswidely commercially available, is considered for alternative use but it can only be used in the assay after it has been evaluated by formal validation study. Thus, a validation study was conducted in our laboratory to determine if BALB/cmouse could also be used in the LLNA: BrdU-ELISA. Methods: Forty-three test substances including 32 LLNA sensitizers and 11 LLNA non-sensitizers, their vehicles and each concentration used were the same as that used in the formal validation study for the LLNA: BrdU-ELISA using CBA/JN mouse. Female BALB/c mice of 8-10 weeks old were randomly allocated to groups (four mice per group). The test substance (25 mu l) or the vehicle alone was applied to the dorsum of both ears daily for 3 consecutive days. A single intraperitoneal injection of 0.5 ml of BrdU (10 mg/ml) solution was given on day 5. On day 6, a pair of auricular lymph nodes fromeach mousewas excised, weighed and stored at-20 degrees C until BrdU-ELISAwas conducted. Results: This validation study for the LLNA: BrdU-ELISA using BALB/c mouse correctly identified 30 of 31 sensitizers and 8 of 11 non-sensitizers. The accuracy, sensitivity, specificity, false positive rate, false negative rate, positive predictivity values and negative predictivity values in this study, which could indicate the performance of the LLNA: BrdU-ELISA using BALB/cmouse, were not different statistically from that of the validation study for the LLNA: BrdU-ELISA using CBA/JN mouse. Discussion: This validation study indicates that BALB/c mouse could be used alternatively in the LLNA: BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals. (C) 2015 Elsevier Inc. All rights reserved.

Application of BALB/c Mouse in the Local Lymph Node Assay:Brdu-Elisa for the Prediction of the Skin Sensitizing Potential of Chemicals.

Intra-laboratory Study to Determine the Reproducibility of LLNA:BrdU-ELISA for the Prediction of the Skin Sensitizing Potential of Chemicals.

A BALB/c Mouse Model for Assessing the Potential Allergenicity of Proteins: Comparison of Allergen Dose, Sensitization Frequency, Timepoint and Sex

Study on variation characteristics of anti-donor specific antibodies in different species of sensitized mice after skin transplantation

A Preliminary Study in Immune Response of BALB/c and C57BL/6 Mice with a Locally Allergic Rhinitis Model

Balb/C Mice Can Be Used to Evaluate Allergenicity of Different Food Protein Extracts

Murine bone marrow-derived dendritic cells as a potential in vitro model for predictive identification of chemical sensitizers

Investigation of the dermal sensitizing potential of traditional medical extracts in local lymph node assays.

Assessment of dermal sensitization by nickel salts in a novel humanized TLR-4 mouse model

A Novel Method for Multiple Cytokines/chemokines DropArray Assay in 5 Μl of Bronchoalveolar Lavage Fluid (BALF) in Mice

Study on the Sensitizing Potential of Shuanghuanglian Injection Using Poplite Lymph Node Assay in C57BL/6J Mice

Assessment of skin sensitization potential of zinc oxide, aluminum oxide, manganese oxide, and copper oxide nanoparticles through the local lymph node assay: 5-bromo-deoxyuridine flow cytometry method

Assessment of Baicalin in Mouse Blood by Monoclonal Antibody-Based Icelisa

Preparation of monoclonal antibodies against neutrophil gelatinase-associated lipocalin (NGAL) and development of an antibody-based chemiluminescence immune quantification assay

The skin sensitization and effect on the activation of lymph nodes CD4~+T cells of trichloroethylene

[In Vitro Evaluation of Cutaneous Allergic Reaction Induced by Chemicals Using Dendritic Cells].

Comparison of Rat(Rattus Norvegicus) Basophilic Leukaemia(RBL)-2H3 and RBL-1 Cell Models for Evaluating Potential Allergenicity of Foods

Benchmarking of BMDC assay and related QSAR study for identifying sensitizing chemicals

Borderline Range Determined Using Data From Validation Study of Alternative Methods for Skin Sensitization: ADRA, IL‐8 Luc Assay, and EpiSensA

Establishment of a Mouse Model of Alternaria-allergic Asthma

Experimental Study of the Effects of Some Antihistamines on the Contact Dermatitis Model of Mice